Dual-Function Microfluidic Chip for Identification and Drug Response Testing of Lung Cancer Organoids

Jiyu Xi, Zewen Wei*, Xin Wu, Kexin Zhang, Huiting Zhao, Yu Zhang

*此作品的通讯作者

科研成果: 书/报告/会议事项章节会议稿件同行评审

摘要

Organoids, as a novel in vitro drug screening platform, have received widespread attention due to their relevance to clinical research as they are derived from patient samples. Lung cancer organoids are categorized into two subtypes: EGFR mutation type and EGFR wild type. EGFR mutation lung cancer organoids exhibit better therapeutic effects with tyrosine kinase inhibitors (TKIs), whereas EGFR wild type lung cancer organoids have better responses to chemotherapy drugs. However, the current lack of a microfluidic chip capable of identifying EGFR mutations in lung cancer organoids and testing their drug response poses a challenge. To address this, we have developed a dual-functional chip that streamlines EGFR mutation identification and drug testing in lung cancer organoids. This method not only reduces time and cost but also enhances drug screening efficiency.

源语言英语
主期刊名Fuzzy Systems and Data Mining IX - Proceedings of FSDM 2023
编辑Antonio J. Tallon-Ballesteros, Raquel Beltran-Barba
出版商IOS Press BV
925-930
页数6
ISBN(电子版)9781643684703
DOI
出版状态已出版 - 12 12月 2023
活动9th International Conference on Fuzzy Systems and Data Mining, FSDM 2023 - Hybrid, Chongqing, 中国
期限: 10 11月 202313 11月 2023

出版系列

姓名Frontiers in Artificial Intelligence and Applications
378
ISSN(印刷版)0922-6389
ISSN(电子版)1879-8314

会议

会议9th International Conference on Fuzzy Systems and Data Mining, FSDM 2023
国家/地区中国
Hybrid, Chongqing
时期10/11/2313/11/23

指纹

探究 'Dual-Function Microfluidic Chip for Identification and Drug Response Testing of Lung Cancer Organoids' 的科研主题。它们共同构成独一无二的指纹。

引用此